AMONDYS 45
NDC 60923-227, casimersen, injection, from Sarepta Therapeutics, Inc..
- Product NDC
- 60923-227
- Status
- Listed
- Labeler
- Sarepta Therapeutics, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213026
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60923-227 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CASIMERSEN50 mg/mL
Pharmacologic classes
Antisense Oligonucleotide [EPC]; Increased Protein Synthesis [PE]; Oligonucleotides, Antisense [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60923-227-02 | 60923022702 | 1 VIAL, SINGLE-USE in 1 CARTON (60923-227-02) / 2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e9e5fd44-eeda-4580-bba1-a734828bbcc3
Use it
Look up 60923-227 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60923-227 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60923-227. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.